Enveric Biosciences Inc Ordinary Shares ENVB 深 沪
已收盘 12-19 16:00:00 美东时间
5.08
+0.025
+0.49%
华盛通- 最 高13.25
- 今 开4.95
- 成交量 6.18万股
- 最 低 4.55
- 昨 收 5.055
- 总市值 2.68亿
- 52周最高 13.25
- 市盈率 静 --
- 换手率 0.12%
- 52周最低 0.27
- 委 比 -34.29%
- 总股本 5268.45万
- 历史最高 300.00
- 量 比 0.41
- 振 幅 172.11%
- 历史最低 0.14
- 每 手 1
- 风险率 1.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Enveric Biosciences Announces Immediate Warrant Exercise, Raising ~$3.1M Gross Proceeds At Reduced $7.05/Share Price
Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced
12-12 02:46
Crude Oil Moves Lower; Photronics Shares Surge After Q4 Results
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaini...
12-11 01:19
What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading?
Enveric Biosciences shares soared 73.82% in after-hours trading after the company received a patent allowance for its EVM301 Series molecules.
12-10 11:31
'DEA Calls For Massive Increases In Psilocybin, Ibogaine And THC Manufacturing This Year To Meet Research Demands' - Marijuana Moment
https://www.marijuanamoment.net/dea-calls-for-massive-increases-in-psilocybin-ibogaine-and-thc-manufacturing-this-year-to-meet-research-demands/The Drug Enforcement Administration (DEA) is proposing a dramatic increase
2024-09-24 01:41
Enveric Biosciences Granted US Patent #12065404 Today For "C4-CARBOXYLIC ACID-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS USED TO TREAT BRAIN NEUROLOGICAL DISORDERS".
https://ppubs.uspto.gov/pubwebapp/external.html?q=(12065404).pn
2024-08-21 03:54
